Tonix Pharmaceuticals (Nasdaq: TNXP) has received FDA approval for Tonmya™, a groundbreaking treatment for fibromyalgia in adults – the first new therapy approved in over 15 years. This non-opioid, sublingual tablet is designed for once-daily bedtime use with rapid bloodstream absorption. Two pivotal Phase 3 clinical trials involving nearly 1,000 patients demonstrated …
Read More »FDA Approves Tonix’s Tonmya for Fibromyalgia, First New Drug in 15 Years
